The Commission accordingly grants Aventis Pharma and Rhône-Poulenc Biochimie a 40 % reduction of the fine that would otherwise have been imposed had it not cooperated with the Commission.
3.3.7.4. Conclusion on the application of the Leniency Notice
The Commission accordingly grants Aventis Pharma and Rhône-Poulenc Biochimie a 40 % reduction of the fine that would otherwise have been imposed had it not cooperated with the Commission.
3.3.7.4. Conclusion on the application of the Leniency Notice